Table 2.
The key data of the studies included in this meta-analysis
| Study | TP | FP | FN | TN | PLR | NLR | SEN% | SPE% | DOR |
|---|---|---|---|---|---|---|---|---|---|
| Inoue [6] | 24 | 0 | 0 | 17 | 35.28 | 0.02 | 1.00 | 1.00 | 1715.00 |
| Ferda [7] | 13 | 1 | 3 | 7 | 6.50 | 0.21 | 0.81 | 0.88 | 30.33 |
| Jolapara [8] | 15 | 0 | 0 | 23 | 46.50 | 0.03 | 1.00 | 1.00 | 1457.00 |
| Liu [9] | 14 | 4 | 1 | 9 | 3.03 | 0.10 | 0.93 | 0.69 | 31.50 |
| White [10] | 23 | 2 | 2 | 7 | 4.14 | 0.10 | 0.92 | 0.78 | 40.25 |
| Ma [11] | 6 | 2 | 9 | 8 | 2.00 | 0.75 | 0.40 | 0.80 | 2.67 |
| Roy [12] | 29 | 7 | 3 | 17 | 3.11 | 0.13 | 0.91 | 0.71 | 23.48 |
PLR=Positive likelihood ratio; NLR=Negative likelihood ratio; TP=True positive; FP=False positive; FN=False negative; TN=True negative, SEN=Sensitivity; SPE=Specificity; DOR=Diagnostic odds ratio.